Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients

Drugs in R and D

Volumn 13, Issue 1, 2013, Pages 37-42

  Hon, Kam Lun ^a   Pong, Nga Hin ^a   Wang, Shuxin Susan ^a   Lee, Vivian W ^b   Luk, Nai Ming ^b   Leung, Ting Fan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CERAMIDE DERIVATIVE; CERAMIDE PRECURSOR LIPIDS AND MOISTURIZING FACTORS; CETAPHIL RESTORADERM LOTION; CETAPHIL RESTORADERM WASH; CORTICOSTEROID; EMOLLIENT AGENT; LIPID; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HYDRATION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OINTMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; PRURITUS; SCORING ATOPIC DERMATITIS INDEX; SKIN WATER LOSS; SLEEP DISORDER; STAPHYLOCOCCUS AUREUS;

ADMINISTRATION, TOPICAL; ADOLESCENT; BEHAVIOR; CERAMIDES; CHILD; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; EMOLLIENTS; FEMALE; HUMANS; LIPIDS; MALE; MEDICATION ADHERENCE; PILOT PROJECTS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 84876208119     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.1007/s40268-013-0004-x     Document Type: Article

References (32)

1. Leung AK, Hon KL, Robson WL. Atopic dermatitis. Adv Pediatr. 2007;54:241-73.
2. Sandilands A, Terron-Kwiatkowski A, Hull PR, O'Regan GM, Clayton TH, Watson RM, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet. 2007;39(5):650-4.
3. Sandilands A, Smith FJ, Irvine AD, McLean WH. Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol. 2007;127:1282-4.
4. Enomoto H, Hirata K, Otsuka K, Kawai T, Takahashi T, Hirota T, et al. Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case-control study. J Hum Genet. 2008;53(7):615-21.
5. Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002;47(2):198-208.
6. Maintz L, Novak N. Getting more and more complex: the pathophysiology of atopic eczema. Eur J Dermatol. 2007;17(4):267-83.
7. Hon KL, Leung AKC. Use of ceramides and related products for childhood-onset eczema. Recent Pat Inflamm Allergy Drug Discov. 2013;7(1):12-9.
8. Hon KL, Wang SS, Pong NH, Leung TF. The ideal moisturizer: a survey of parental expectations and practice in childhood-onset eczema. J Dermatol Treat. 2013;24(1):7-12.
9. Williams HC, Burney PG, Pembroke AC, Hay RJ. The UK Working Party's diagnostic criteria for atopic dermatitis: III. independent hospital validation. Br J Dermatol. 1994;131(3):406-16.
10. Hon KL, Wong KY, Leung TF, Chow CM, Ng PC. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD Index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol. 2008;9(1):45-50.
11. [No authors listed.] Severity scoring of atopic dermatitis: the SCORAD Index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186(1):23-31.
12. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD Index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-9.
13. Hon KL, Wang SS, Lau Z, Lee HC, Lee KK, Leung TF, et al. Pseudoceramide for childhood eczema: does it work? Hong Kong Med J. 2011;17(2):132-6.
14. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004;113(5):651-7.
15. Hon KL, Lam MC, Leung TF, Kam WY, Li MC, Ip M, et al. Clinical features associated with nasal Staphylococcus aureus colonisation in Chinese children with moderate-to-severe atopic dermatitis. Ann Acad Med Singap. 2005;34(10):602-5.
16. Hon KL, Wang SS, Lee KK, Lee VW, Fan LT, Ip M. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: friend or foe? J Drugs Dermatol. 2012;11(7):861-4.
17. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;2:44-7.
18. Hanifin JM. Atopic dermatitis. J Am Acad Dermatol. 1982;6(1):1-13.
19. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-6.
20. Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122(4):812-24.
21. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6(4):328-40.
22. Leung DY, Nicklas RA, Li JT, Bernstein IL, Blessing-Moore J, Boguniewicz M, et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol. 2004;93(3 Suppl 2):S1-21.
23. Lancaster W. Atopic eczema in infants and children. Community Pract. 2009;82(7):36-7.
24. Tarr A, Iheanacho I. Should we use bath emollients for atopic eczema? BMJ. 2009;339:b4273.
25. Hon KL, Leung TF, Wong Y, Li A, Fok TF, et al. A survey of bathing and showering practices in children with atopic eczema. Clin Exp Dermatol. 2005;30(4):351-4.
26. Park KY, Kim DH, Jeong MS, Li K, Seo SJ. Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis. J Korean Med Sci. 2010;25(5):766-71.
27. Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis. 2008;81(1):87-91.
28. Madaan A. EpiCeram for the treatment of atopic dermatitis. Drugs Today. 2008;44(10):751-5.
29. Hon KL, Ching GK, Leung TF, Choi CY, Lee KK, Ng PC. Estimating emollient usage in patients with eczema. Clin Exp Dermatol. 2010;35(1):22-6.
30. Kim HJ, Park HJ, Yun JN, Jeong SK, Ahn SK, Lee SH. Pseudoceramide- containing physiological lipid mixture reduces adverse effects of topical steroids. Allergy Asthma Immunol Res. 2011;3(2):96-102.
31. Roos TC, Geuer S, Roos S, Brost H. Recent advances in treatment strategies for atopic dermatitis. Drugs. 2004;64(23):2639-66.
32. Baumer JH. Atopic eczema in children, NICE. Arch Dis Child Educ Pract Ed. 2008;93(3):93-7.